Study guide
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities
Key Takeaways Explain This Topic AI
Standard 2.1 requires a Cancer Committee Chair, Cancer Liaison Physician, diagnostic radiologist, pathologist, surgeon, medical oncologist and radiation oncologist, plus a cancer program administrator, oncology nurse, social worker and Oncology Data Specialist.
The six required coordinators oversee cancer conferences (2.5), quality improvement (7.3), registry quality (6.1 and 4.3), clinical research (9.1), psychosocial services (5.2) and survivorship (4.8); one person may hold at most two coordinator roles.
An ODS on the cancer committee may serve only as the Cancer Conference Coordinator and/or the Cancer Registry Quality Coordinator.
The committee must meet at least once in each calendar quarter (Standard 2.3), and each required member or designated alternate must attend at least 75% of meetings (Standard 2.4).
The Cancer Liaison Physician presents NCDB data to the committee at least twice each calendar year and meets with the site reviewer (Standard 2.2).
Last updated: September 2026
Why the cancer committee matters to the registrar
The cancer committee governs a CoC-accredited program. The registry does much of the committee's documentation work: preparing data, tracking attendance, recording minutes and reports, and keeping the evidence that site reviewers check. CoC compliance for a year is judged largely from the cancer committee minutes , so knowing who must attend and what must be reported is core Domain 2 knowledge. The requirements below come from Optimal Resources for Cancer Care , 2020 Standards, updated October 2025.
Standard 2.1: Required membership
Category Required members Notes
Physicians Cancer Committee Chair (any specialty); Cancer Liaison Physician (CLP); diagnostic radiologist; pathologist; surgeon (general surgeon or surgical specialist involved in cancer care); medical oncologist; radiation oncologist If all radiation oncology is provided by referral and no radiation oncologist is on the medical staff, a radiation oncologist is recommended but not required. The Chair and the CLP may also represent a required physician specialty.
Non-physicians Cancer program administrator (with administrative oversight and budget authority); oncology nurse; social worker (OSW-C preferred); Oncology Data Specialist (ODS) —
Coordinators Cancer Conference Coordinator (Standard 2.5); Quality Improvement Coordinator (7.3); Cancer Registry Quality Coordinator (6.1 and 4.3); Clinical Research Coordinator (9.1); Psychosocial Services Coordinator (5.2); Survivorship Program Coordinator (4.8) Each coordinator has eligibility criteria set by the standard. For example, the Psychosocial Services Coordinator is an oncology social worker, advanced practice nurse, psychologist or other trained mental health professional.
Strongly recommended, but not required: specialty physicians for the program's five major cancer sites, a palliative care professional, a genetics professional, a registered dietitian nutritionist, a rehabilitation professional, a pharmacist, a spiritual care representative and an American Cancer Society representative.
Rules that exam questions test
Coordinator limits. One individual may serve in a maximum of two coordinator roles and may also represent one required physician or non-physician specialty. For example, the medical oncologist may also be the Clinical Research Coordinator and the Survivorship Program Coordinator.
ODS limits. An ODS may serve only as the Cancer Conference Coordinator and/or the Cancer Registry Quality Coordinator. The Cancer Registry Quality Coordinator does not have to be an ODS; the restriction is on which coordinator roles an ODS member may take.
Appointments. Required members are appointed and documented in the minutes at the first meeting of a calendar year , at least once each accreditation cycle. If a required member leaves, a replacement is appointed at the next meeting.
CLP as quality leader. The CLP may also serve as the Quality Improvement Coordinator and is the Chair's alternate. CoC encourages, but does not require, filling the Chair and CLP roles with two different people.
Standard 2.2: Cancer Liaison Physician
The CLP is a physician of any specialty on the active medical staff and serves as the committee's physician quality leader. The CLP must:
Identify, analyze and present NCDB data specific to the program, with emphasis on areas of concern or unmet benchmarks, at a minimum of two cancer committee meetings each calendar year . The CLP or the CLP's alternate gives these reports.
Attend the CoC site visit and meet the site reviewer.
CLP reports cannot double as the Rapid Cancer Reporting System reports required by Standard 6.4.
Standard 2.3: Meeting frequency
The committee meets at least once each calendar quarter (January–March, April–June, July–September, October–December). Compliance depends on having a meeting in every quarter, not on the total number of meetings. CoC recommends scheduling in the first month of each quarter so that a cancelled meeting can be rescheduled. The triennial site visit does not count as a meeting. Optional subcommittees may do the work, but their reports must be presented to and approved by the full committee.
Standard 2.4: Attendance
Each required member, or that member's designated alternate , attends at least 75% of the meetings held each calendar year. With four meetings, that means at least three for each required role.
Designating an alternate is optional . There may be only one alternate per required role , and the alternate must be qualified for the role (for example, another medical oncologist). A person may be the alternate for only one individual.
Attendance is calculated per role : the member's and the alternate's attendance count together.
Remote attendance by teleconference or videoconference counts if the attendee has access to the meeting documents.
Other annual activities the committee oversees
Standard What the committee must do each year
7.4 Cancer Program Goal Establish one program goal, documented in the minutes. SMART criteria are recommended. Document at least two substantive status updates in the same year. A goal may extend into a second year, but a new goal must still be set each year. The goal cannot duplicate another standard's requirement.
8.2 Cancer Prevention Event Hold at least one event aimed at reducing the number of cancer diagnoses, such as risk reduction or vaccination. Internet-only, social-media-only or mail-only campaigns without real-time interaction, and routine education given in the regular course of business, do not qualify.
8.3 Cancer Screening Event Hold at least one event aimed at reducing late-stage presentation, following screening guidelines, with a documented process for follow-up of all positive findings .
Annual reports Receive the reports that specific standards require. The Standard 2.5 conference report and the reports for Standards 4.4, 4.5, 4.8, 5.2 and 9.1 are due at the first-quarter meeting of the following year and must contain a full calendar year of data. Standards such as 6.1, 7.1, 7.2 and 7.3 must be presented within the calendar year of the activity.
Example: auditing one year of minutes
A registrar preparing for a site visit checks four meetings (February, May, August and November):
Quarters: one meeting in each quarter, so Standard 2.3 is met.
Pathology role: the pathologist attended two meetings and the designated alternate pathologist attended one, so the role attended three of four (75%), and Standard 2.4 is met.
Radiation oncology role: one meeting only, with no alternate designated, so the role is at 25% and the standard is not met for that role.
CLP: NCDB presentations are documented in May and November, so Standard 2.2 is met.